Table 2 Lymph node size and [18F]CFA uptake before and after CIT in melanoma patients.

From: Noninvasive in vivo deoxycytidine kinase (dCK)-PET identifies tumor-draining lymph nodes upon immune checkpoint inhibitor therapy

Patient

Lymph node

Pre-CIT

Post-CIT

Size

[mm]

SUVmax

[g/mL]

Size

[mm]

SUVmax

[g/mL]

SUVmax increase [%]

27-year-old man (Fig. 5a–f)

Regional

20 × 14

2.8

17 × 11

5.2

85.7

Distal

17 × 8

2.2

20 × 10

4.8

118

47-year-old man (Fig. 5g–l)

Regional 1

44 × 31

2.6

38 × 26

3.5

34

Regional 2

26 × 21

1.7

27 × 19

3.6

111

Back to article page